Tag: DRYS

AXXE | Axxess Pharma, Inc. & Extended Watchlist

Axxess Pharma, Inc. AXXE
–
We’re touching base with AXXE again this morning, as the company has made some exciting announcements over the past couple of days including the acquisition of assets previously belonging to Revive Bioscience Inc., a Canadian OTC healthcare company, a move that widens AXXE’s catalog of pharma products significantly. Even more exciting is the fact that Revive held the rights to several branded OTC products endorsed by professional athletes in many major American sports including the NFL, NHL, and more.
–

Additionally, in a PR from yesterday we learned that AXXE has also made an addition to an already strong management team, with the appointment of Robert Tallack, who will serve as VP of Sales and Marketing. You can read more in depth about both developments by clicking through the press links below, but first, we’re going to take a look at how the AXXE chart is faring via the following video:

Be sure to check out the Exclusive Interview our sister site, Stock Traders Talk, conducted with AXXE President Dr. Daniel Bagi last week:
AXXE Interview

You can also take a look at our initial report on the company:
AXXE Report

Extended Watchlist:
FREE, DRYS, GOGO, RAD

Blue Horseshoe Stocks: FREE & Extended Watchlist

FreeSeas, Inc. FREE

FREE set off our volume scanners yesterday, a stock that had recently been trading in the .17-.26 range until a surge of buying pushed it through a triple top, breaking recent resistance at the 50DMA with authority.

Whenever our searches turn up a momentous play like this one, we have to give it our attention. As we pointed out on the chart below, the next areas of resistance come at .33 and .38, and other indicators appear to be favorable. FREE is definitely going to be on our watchlists as we cruise into midweek.


Extended Watchlist:
PLUG, INO, DRYS, LLEN, NEWL, NVIV

ENTB, BMSN, VELT & Extended Watchlist

Entest BioMedical, Inc. ENTB
&
BioMatrix Scientific Group, Inc. BMSN

We’ve talked about each of these stocks in the past, and wanted to bring them back into the discussion this morning. Both of these subpenny biomed plays has been trading in a sideways channel and have found new levels of support, and we’d like to start monitoring for any signs of increasing volume. In both cases, a relatively small amount of buying pressure could give way to some serious gains.

Earlier this year, ENTB brought us gains in excess of 960% as we called its run from .001 to .0104, and BMSN generated the opportunity at a mind-numbing 5400% in in monstrous spike from .0003 to .0165. Thus we are well aware of each of these stocks capability of making huge moves. We’ll be following closely through the upcoming fall season for any signs of history repeating itself.

Velti Plc. VELT

We added VELT to our watchlists yesterday, stating it was “gapping down to all time lows…” and to “keep on watch for a potential bounce”. We observed the stock fall to a low of .33, and this morning it appears that VELT is gapping up to the tune of 17% It’s possible that this is a signal of the bounce we were looking for, so this one will be near the top of our tickers today.

Extended Watchlist:
VHGI, NPWZ, DRYS, SUNE, CVO, CCCR, CYTK